Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer - Top-Institutions - MDSpire

Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer

  • By

  • Xinglong Lu

  • Xiang Cui

  • Hao Chen

  • Jianling Zhang

  • Shengbing Zhao

  • Baoshun Yang

  • Yang Yang

  • Nan Du

  • Wenxiang Ma

  • Jixi An

  • Yongjiang Yu

  • May 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The First Hospital of Lanzhou University
    The First Hospital of Lanzhou University

    Lanzhou, Gansu

    Key Differentiators

    • Oncology

  • #2

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology

  • #3

    Peking University Cancer Hospital
    Peking University Cancer Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

Original Source(s)

Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer

  • by Xinglong Lu, Xiang Cui, Hao Chen, Jianling Zhang, Shengbing Zhao, Baoshun Yang, Yang Yang, Nan Du, Wenxiang Ma, Jixi An, Yongjiang Yu

  • May 25, 2026

Related Content

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report